A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Plasma cells are terminally differentiated B cells specialized for high-rate antibody secretion. They undergo dramatic morphological and metabolic changes: expanded endoplasmic reticulum, increased protein synthesis machinery, and loss of surface Ig expression. A single plasma cell secretes hundreds to thousands of antibody molecules per second, making them the cellular factories of humoral immunity.
Examine the transcriptional reprogramming during plasma cell differentiation (e.g., downregulation of B cell identity genes like Pax5). Study the bioenergetic demands of antibody synthesis and the organellar changes required.
Plasma cells do not divide; they are post-mitotic effector cells. Not all antibody-secreting cells are long-lived plasma cells—most are short-lived and die within days to weeks.
From your study of B cell activation and germinal centers, you know that activated B cells undergo somatic hypermutation and class switching to produce high-affinity, isotype-switched antibodies. From your understanding of protein synthesis and the endomembrane system, you know that secreted proteins must be synthesized on the rough endoplasmic reticulum, processed in the Golgi, and exported via secretory vesicles. Plasma cells represent the endpoint of B cell differentiation — cells that have abandoned all other functions to become single-purpose antibody factories, producing and secreting immunoglobulin at an extraordinary rate.
The transformation from an activated B cell to a plasma cell involves a dramatic transcriptional reprogramming. The master B cell transcription factor Pax5, which maintains B cell identity and suppresses plasma cell genes, is downregulated. In its place, Blimp-1 (encoded by *PRDM1*) and IRF4 drive the plasma cell program: they shut down genes involved in antigen presentation, BCR signaling, and cell cycling, while massively upregulating genes for immunoglobulin heavy and light chains, the secretory machinery, and metabolic enzymes that fuel biosynthesis. The cell stops expressing surface immunoglobulin (switching instead to the secreted form of the antibody through alternative mRNA splicing) and exits the cell cycle permanently. A plasma cell is post-mitotic — it will never divide again.
The morphological changes are equally dramatic and directly reflect the cell's new function. The endoplasmic reticulum expands enormously to accommodate the massive volume of antibody protein being synthesized — electron microscopy reveals plasma cells packed with parallel stacks of rough ER, giving them a characteristic "clock-face" nucleus pushed to one side by the swollen cytoplasm. The Golgi apparatus enlarges to handle glycosylation and packaging. Mitochondria proliferate to supply the ATP needed for this biosynthetic output. A single plasma cell can secrete hundreds to thousands of antibody molecules per second — roughly 2,000 IgG molecules per second in some estimates — making it one of the most biosynthetically active cell types in the body. The unfolded protein response (UPR) pathway is constitutively activated to manage the ER stress that comes with producing this volume of protein.
Not all plasma cells share the same fate. Short-lived plasmablasts emerge early in the immune response — within days of B cell activation — and produce the first wave of antibodies. These cells have modest secretory capacity, retain some proliferative ability, and survive only days to weeks before dying by apoptosis. Long-lived plasma cells, by contrast, emerge primarily from germinal center reactions, migrate to survival niches in the bone marrow, and can persist for years or even a lifetime. Their survival depends on signals from stromal cells in the bone marrow microenvironment, including cytokines like APRIL, BAFF, and IL-6, as well as direct cell-cell contact. These long-lived plasma cells are responsible for the sustained antibody titers that protect against re-infection — they are the reason that serum antibodies against measles can be detected decades after vaccination, continuously replenished by a stable population of bone marrow residents that the immune system established long ago.